1 recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow Neutrolis: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA NTR1011 - SLE (Systemic Lupus), RA - Rheumatoid Arthritis | Phase 1 | Recruiting | Neutrolis | 24 | 2026-07-15 | 2026-07-20 |
| Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients NTR-441, Placebo - Covid19 | Phase 1 | Terminated | Neutrolis | 52 | 2021-04-14 | 2024-01-19 |
Arthritis, Rheumatoid (1) · COVID-19 (1) · Lupus Erythematosus, Systemic (1)
NTR-441 (1)
Austria (1) · Ukraine (1) · United States (1)